NR4A2 and Parkinson disease: Notably, recent studies have identified Nurr1 as the upstream mediator of mitochondrial dysfunction in Parkinson’s disease, glioblastoma multiform brain tumor, and cerebral ischemia/reperfusion injury [10, 11, 12, 13, 14].